Press release
Vector Control Market Projected to Reach $20.37 Billion by 2023 | Key Players are Bayer AG, Syngenta AG, BASF SE, Bell Laboratories, Inc, Rentokil Initial plc, FMC Corporation
The vector control market is projected to grow at a CAGR of 5.13% from 2018 to 2023, to reach a projected value of USD 20.37 Billion by 2023. The increasing awareness about public health has led to the adoption of vector/pest control services on a regular basis in the residential, commercial, and industrial sectors.The years considered for the study are as follows:
1. Base year – 2017
2. Estimated year – 2018
3. Projected year – 2023
4. Forecast period – 2018 to 2023
The objectives of the report:
1. Determining and projecting the size of the vector control market with respect to vector type, end-use sector, method of control, and regional markets over the period ranging from 2018 to 2023
2. Identifying attractive opportunities in the market by determining the largest and fastest-growing markets across regions
3. Identifying drivers and restraints impacting the global market for vector control
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=265146798
The chemical segment, by method of control, was the largest in the vector control market in 2017.
The chemical-based method of control was observed to be the most preferred method, particularly in the North American region as it is highly effective in eliminating disease-causing harmful pests. Chemicals such as Pyrethroids and Fipronil have been widely used to control and eliminate disease-causing adult mosquitoes and larvae of such harmful mosquitoes. This market has witnessed an increased demand from endemic countries such as Tanzania, Uganda, Mozambique, and certain Asian countries such as India, China, and Indonesia.
Rodents, by vector type, is projected to witness the highest growth rate over the next five years.
The rodent control segment is projected to grow at the highest rate during the forecast period owing to the increasing initiative programs by public health authorities to control global outbreaks of lethal diseases such as Hantavirus and Hemorrhagic fever with renal syndrome (HFRS). This is followed by the insect control segment owing to the high demand of mosquito control solutions in the North American and Asia Pacific regions.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=265146798
Significant market potential is witnessed in emerging Asian countries.
The vector control market has a high potential in emerging markets such as China and India since the climatic conditions and ineffective waste management in the Asia Pacific region are conducive to insect and rodent growth. There is also an increase in the middle-class population, who are aware of vector-borne diseases leading to the growing demand for vector control products for vectors such as mosquitoes and rodents.
This report includes a study of marketing and development strategies, along with the product and/or service portfolios of leading companies. Key companies in the market include vector control product manufacturers and service providers such as Bayer AG (Germany), Syngenta AG (Switzerland), BASF SE (Germany), Bell Laboratories, Inc. (US), Rentokil Initial plc (UK), FMC Corporation (US), Ecolab (US), The Terminix International Company LP (US), Rollins, Inc. (US), Arrow Exterminators, Inc. (US), Massey Services Inc. (US), and Anticimex Group (Sweden).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
Email: sales@marketsandmarkets.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Vector Control Market Projected to Reach $20.37 Billion by 2023 | Key Players are Bayer AG, Syngenta AG, BASF SE, Bell Laboratories, Inc, Rentokil Initial plc, FMC Corporation here
News-ID: 1723339 • Views: …
More Releases from MarketsandMarkets.com

Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Medical Robots Market in terms of revenue was estimated to be worth $16.0 billion in 2024 and is poised to reach $33.8 billion by 2029, growing at a CAGR of 16.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the medical robots market is driven by the aging population and rising chronic diseases, improving reimbursement scenario, and subsequent advancements in healthcare funding & infrastructure.…

Concrete Surface Retarders Market worth $89.4 million by 2023 : Major Players ar …
The report "Concrete Surface Retarders Market by Raw Material (Organic Agents and Inorganic Agents), Type (Water-based and Solvent-based), Application (Residential and Commercial), and Region (North America, Europe, Asia Pacific) - Global Forecast to 2023", The concrete surface retarders market is projected to grow from USD 72.7 million in 2018 to USD 89.4 million by 2023, at a CAGR of 4.2% between 2018 and 2023. Increase in urban population, demand for…
Precast Concrete Market worth $174.1 billion by 2025 | Major Players are Lafarge …
The report "Precast Concrete Market by Element (Columns & Beams, Floors & Roofs, Girders, Walls & Barriers, Utility Vaults, Pipes, Paving Slabs), Construction Type, End-use Sector (Residential, Non-residential) - Global Forecast to 2025" The global precast concrete market size is projected to grow from USD 130.6 billion in 2020 to USD 174.1 billion by 2025, at a CAGR of 5.9% from 2020 to 2025. The market is projected to grow…
Fire Stopping Materials Market worth $2.4 billion by 2026 : Major Players are Hi …
The report "Fire Stopping Materials Market by Type (Sealants, Mortar, Boards, Putty &Putty Pads, Cast-in Devices), by Application (Electrical, Mechanical, Plumbing), End-Use (Commercial, Industrial & Residential), and Region - Global Forecast to 2026" MarketsandMarkets: The fire stopping materials market is projected to reach USD 2.4 billion by 2026, at a CAGR of 11.6% from USD 1.4 billion in 2021. Fire stopping is a fire protection system for sealings of any…
More Releases for MarketsandMarkets™
Biomaterials Market Worth $64.2 billion | MarketsandMarkets™
Biomaterials Market in terms of revenue was estimated to be worth $45.2 billion in 2024 and is poised to reach $64.2 billion by 2029, growing at a CAGR of 7.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. The biomaterials market is estimated to grow at a CAGR of 7.3% during the forecast period of 2024 to 2029. The important factors impacting market growth are the growing…
Cell Expansion Market Worth $26.7 billion | MarketsandMarkets™
Cell Expansion Market in terms of revenue was estimated to be worth $14.3 billion in 2024 and is poised to reach $26.7 billion by 2029, growing at a CAGR of 13.3% from 2024 to 2029 according to a new report by MarketsandMarkets™. Some factors contributing to the growth of the global market includes increasing R&D investments in cell based research, growing focus on personalized medicine, and increasing number of strategic…
Apheresis Market Worth $3.9 billion | MarketsandMarkets™
Apheresis Market in terms of revenue was estimated to be worth $2.6 billion in 2024 and is poised to reach $3.9 billion by 2029, growing at a CAGR of 8.8% from 2024 to 2029 according to a new report by MarketsandMarkets™.
The growth in the apheresis market is driven by rise in demand for source plasma from biopharmaceutical companies, upsurging demand for blood components and favourable reimbursement for apheresis. The increasing…
Medical Robots Market Worth $33.8 billion | MarketsandMarkets™
Medical Robots Market in terms of revenue was estimated to be worth $16.0 billion in 2024 and is poised to reach $33.8 billion by 2029, growing at a CAGR of 16.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The growth in the medical robots market is driven by the aging population and rising chronic diseases, improving reimbursement scenario, and subsequent advancements in healthcare funding & infrastructure.…
Pipette Calibrators Market Worth $391 million | MarketsandMarkets™
Pipette Calibrators Market in terms of revenue was estimated to be worth $286 million in 2024 and is poised to reach $391 million by 2029, growing at a CAGR of 6.5% from 2024 to 2029 according to a new report by MarketsandMarkets™.
The growth of this market is majorly driven by rise in genomics and proteomics research, growth in portable and handheld devices, and establishment of new research facilities by pharmaceutical…
Mice Model Market Worth $2.2 billion | MarketsandMarkets™
Mice Model Market in terms of revenue was estimated to be worth $1.5 billion in 2024 and is poised to reach $2.2 billion by 2029, growing at a CAGR of 8.1% from 2024 to 2029 according to a new report by MarketsandMarkets™. The rise in chronic diseases, such as cancer, diabetes, and cardiovascular disorders, and growing need for reliable and predictive animal models to facilitate drug discovery and development are…